Status:
UNKNOWN
Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of Sepsis Scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient With Acute Myeloid Leukemia Treated With Intensive Chemotherapy
Lead Sponsor:
A.O.U. Città della Salute e della Scienza
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
18-70 years
Brief Summary
Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of sepsis scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient Wit...
Eligibility Criteria
Inclusion
- Diagnosis of non M3 Acute Myeloid Leukemia according to WHO (World Health Organization) 2008 criteria
- Age \>= 18 years and \<= 70 years
- Patient had received intensive chemotherapy either as induction or consolidation regimen
- Period of observation: January 2001 - December 2019
- Written informed consent
Exclusion
- Diagnosis of Acute Promyelocytic Leukemia (M3 AML)
- Age \< 18 or \>70 years
- Patient had not received intensive chemotherapy
Key Trial Info
Start Date :
March 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05249894
Start Date
March 23 2022
End Date
September 1 2022
Last Update
March 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOU Città della Salute e della Scienza di Torino
Torino, Italy, 10126